TrialAmerican journal of respiratory and critical care medicine2022

An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study).

Aliasgar Esmail et al.PubMed ↗Publisher ↗

No numbers read from the abstract.